Overview

Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Healthy Pediatric Participants From Birth to < 1 Year With Influenza-Like Symptoms

Status:
Recruiting

Trial end date:
2022-08-02

Target enrollment:

Participant gender:

Summary

This study will evaluate the safety, pharmacokinetics and efficacy of baloxavir marboxil in healthy pediatric participants from birth to <1 year with influenza like symptoms

Phase:

Phase 3

Details

Lead Sponsor:

Hoffmann-La Roche

Treatments:

Baloxavir